SCHEMBL4698315

SCHEMBL4698315

CCOC(=O)CN(C)C(=O)c1cnc(NNC(=S)NC2c3ccccc3CCc3ccncc32)c(Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 8/20 0.34
GPBAR1 Q8TDU6 1/20 0.33
F10 P00742 1/20 0.32
P2RY12 Q9H244 2/20 0.32
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32
PDK3 Q15120 1/20 0.32
PDK4 Q16654 1/20 0.32
BDKRB2 P30411 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.31
TAS1R1 Q7RTX1 1/20 0.31
PDCD1 Q15116 1/20 0.31
CD274 Q9NZQ7 1/20 0.31
ALDH1A1 P00352 2/20 0.31
GAA P10253 2/20 0.31
AGTR1 P30556 2/20 0.31
HTT P42858 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
LMNA P02545 1/20 0.31
ALOX12 P18054 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4702236 0.96 P2RY12 (0.34) F10P2RY12PDK1PDK2PDK3
SCHEMBL4698835 0.90 ROCK2 (0.36) ROCK2BDKRB2ALDH1A1GAAAGTR1
SCHEMBL4698936 0.88 BDKRB2 (0.36) ROCK2F10P2RY12PDK1PDK2
SCHEMBL4698850 0.86 BDKRB2 (0.35) ROCK2BDKRB2TAS1R3TAS1R1ALDH1A1
SCHEMBL4699886 0.84 ROCK2 (0.38) ROCK2PDK1PDK2PDK3PDK4
SCHEMBL6386247 0.82 ALDH1A1 (0.37) ROCK2ALDH1A1GAAAGTR1HTT
SCHEMBL4699908 0.80 RAB9A (0.40) ROCK2PDK1PDK2PDK3PDK4
SCHEMBL6386788 0.80 BDKRB2 (0.39) ROCK2BDKRB2ALDH1A1SMN1; SMN2LMNA
SCHEMBL4698844 0.79 ROCK2 (0.34) ROCK2GPBAR1ALDH1A1SMN1; SMN2LMNA
SCHEMBL4703627 0.78 KMT2A (0.37) ROCK2PDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458684-B1 THERAPEUTIC HETEROCYCLES AS BRADYKININ B2 RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2008-01-16 EP claimed